![Nautilus neurosciences, inc.](/api/images/company-pic/0-868487-company.jpg)
Contact us
About company
Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected by neurological disorders. In the first half of 2010, Nautilus intends to launch a novel product, CAMBIA� (diclofenac potassium for oral solution). Nautilus is backed by Tailwind Capital, a leading private equity firm that invests in health care, business services and media/communications companies.
US
Unknown
Not verified company
Business transparency
- Did not verified company info
- Ask their customers for reviews
- Did not replied to negative reviews